328 related articles for article (PubMed ID: 25624675)
1. Adherence to topical glaucoma medications in Ethiopian patients.
Tamrat L; Gessesse GW; Gelaw Y
Middle East Afr J Ophthalmol; 2015; 22(1):59-63. PubMed ID: 25624675
[TBL] [Abstract][Full Text] [Related]
2. Adherence to topical glaucoma medications and associated factors in Gondar University Hospital Tertiary Eye Care Center, northwest Ethiopia.
Anbesse DH; Yibekal BT; Assefa NL
Eur J Ophthalmol; 2019 Mar; 29(2):189-195. PubMed ID: 29747522
[TBL] [Abstract][Full Text] [Related]
3. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia.
Mehari T; Giorgis AT; Shibeshi W
BMC Ophthalmol; 2016 Aug; 16():131. PubMed ID: 27485739
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive medication adherence and associated factors among adult hypertensive patients at Jimma University Specialized Hospital, southwest Ethiopia.
Asgedom SW; Atey TM; Desse TA
BMC Res Notes; 2018 Jan; 11(1):27. PubMed ID: 29335003
[TBL] [Abstract][Full Text] [Related]
5. Determinants of medication adherence to topical glaucoma therapy.
Dreer LE; Girkin C; Mansberger SL
J Glaucoma; 2012; 21(4):234-40. PubMed ID: 21623223
[TBL] [Abstract][Full Text] [Related]
6. Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan.
Hwang DK; Liu CJ; Pu CY; Chou YJ; Chou P
JAMA Ophthalmol; 2014 Dec; 132(12):1446-52. PubMed ID: 25211300
[TBL] [Abstract][Full Text] [Related]
7. Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia.
Melaku MW; Yibekal BT; Demilew KZ
PLoS One; 2023; 18(4):e0284200. PubMed ID: 37099553
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
[TBL] [Abstract][Full Text] [Related]
9. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
[TBL] [Abstract][Full Text] [Related]
10. A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan.
Tsumura T; Kashiwagi K; Suzuki Y; Yoshikawa K; Suzumura H; Maeda T; Takeda R; Saito H; Araie M
Int Ophthalmol; 2019 Feb; 39(2):375-383. PubMed ID: 29330811
[TBL] [Abstract][Full Text] [Related]
11. Factors Affecting Adherence to Topical Glaucoma Therapy: A Quantitative and Qualitative Pilot Study Analysis in Sydney, Australia.
Spencer SKR; Shulruf B; McPherson ZE; Zhang H; Lee MB; Francis IC; Bank A; Coroneo MT; Agar A
Ophthalmol Glaucoma; 2019; 2(2):86-93. PubMed ID: 32672609
[TBL] [Abstract][Full Text] [Related]
12. Automated telecommunication-based reminders and adherence with once-daily glaucoma medication dosing: the automated dosing reminder study.
Boland MV; Chang DS; Frazier T; Plyler R; Jefferys JL; Friedman DS
JAMA Ophthalmol; 2014 Jul; 132(7):845-50. PubMed ID: 24831037
[TBL] [Abstract][Full Text] [Related]
13. Glaucoma severity and medication adherence in a county hospital population.
Ung C; Zhang E; Alfaro T; Murakami Y; Zhang M; Seider MI; Lin SC; Singh K
Ophthalmology; 2013 Jun; 120(6):1150-7. PubMed ID: 23453512
[TBL] [Abstract][Full Text] [Related]
14. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
[TBL] [Abstract][Full Text] [Related]
15. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring.
Hermann MM; Bron AM; Creuzot-Garcher CP; Diestelhorst M
J Glaucoma; 2011 Oct; 20(8):502-8. PubMed ID: 20852438
[TBL] [Abstract][Full Text] [Related]
16. Inpatient Adherence to Topical Glaucoma Medications before and after an Educational Intervention.
Mammo DA; Strampe M; Naravane A; Mallory PW; Boysen J; Wright MM
Ophthalmol Glaucoma; 2020; 3(5):339-342. PubMed ID: 32980036
[TBL] [Abstract][Full Text] [Related]
17. Real-world assessment of topical glaucoma medication persistence rates based on national pharmaceutical claim data in a defined population.
Zhu Z; Jiang Y; Wang W; Scheetz J; Shang X; Zhang L; He M
Clin Exp Ophthalmol; 2019 Sep; 47(7):881-891. PubMed ID: 31034700
[TBL] [Abstract][Full Text] [Related]
18. Adherence to topical glaucoma medication during hospitalization.
Yousuf SJ; Jones LS
J Glaucoma; 2011 Dec; 20(9):573-6. PubMed ID: 21048511
[TBL] [Abstract][Full Text] [Related]
19. Morning dosing of once-daily glaucoma medication is more convenient and may lead to greater adherence than evening dosing.
Ford BA; Gooi M; Carlsson A; Crichton AC
J Glaucoma; 2013 Jan; 22(1):1-4. PubMed ID: 21946541
[TBL] [Abstract][Full Text] [Related]
20. Adherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoring.
Hermann MM; Papaconstantinou D; Muether PS; Georgopoulos G; Diestelhorst M
Acta Ophthalmol; 2011 Jun; 89(4):e300-5. PubMed ID: 21106046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
